Looking for a continuous glucose monitor (CGM)?
Check out the features offered by the Guardian™ Connect CGM system.
Reasons to get started with Medtronic
1. Predictive alerts
Only the Guardian™ Connect CGM system lets you choose alerts between 10-60 minutes in advance of both highs and lows.1 The Guardian™ Connect system detected up to 90.5% of lows without predictive alerts turned on and 98.5% of lows with the help of predictive alerts.2,3
2. Customizable notifications
Only the Guardian™ Connect CGM system has “Max Volume at Night,” enabling you to set a higher volume alert for nighttime lows or mute alerts for daytime events.
3. Push notifications of glucose data and alerts
The Guardian™ Connect system provides real-time readings with sensor glucose data transmitted to your compatible smartphone every five minutes. At your fingertips, you’ll see your current sensor glucose and trend direction including predictive and threshold alerts. You can also use your compatible smartwatch to receive discreet notifications.
4. Bluetooth connectivity
The Guardian™ 4 sensor is our most accurate sensor— the same sensor that powers our hybrid closed loop insulin pump system. It connects to the transmitter which sends sensor data via Bluetooth®* to your compatible smartphone.
5. Automatic uploads
Sharing data with your care partners or healthcare provider is seamless with automatic uploads to CareLink™ Personal software. You choose who can view your glucose data and receive text alerts.
Take the next step today! Fill out the form below to get started.
We will start the process of determining your insurance or pharmacy coverage. A member of our team will reach to you about your eligibility. If you have questions, please contact us at 1-888-882-8602 (M-F, 9 a.m.-6 p.m. CT).
References
1 The system is intended to compliment, not replace, information obtained from standard blood glucose monitoring devices. All therapy adjustments should be based on measurements obtained from standard blood glucose monitoring devices. All therapy adjustments should be based on measurements obtained using a home blood glucose meter and not on values provided by the system.
2 Guardian™ Connect system SSED, page 19, Table 5. 90.5% Glucose Correct Detection Rate without Predictive Alerts at both 15 and 30 minutes when worn on the abdomen.
3 Guardian™ Connect system SSED, page 19, Table 5. 98.5% Glucose Correct Detection Rate based on Predictive Alerts at 30 minutes when worn on the abdomen.
* The Bluetooth® word mark and logos are registered trademarks owned by Bluetooth SIG, Inc. and any use of such marks by Medtronic is under license.
Important Safety Information: Guardian™ Connect CGM System
The Guardian™ Connect system requires a prescription and is indicated for continuous or periodic monitoring of glucose levels in the interstitial fluid under the skin, in patients (14 to 75 years of age) with diabetes mellitus. The system is intended to complement, not replace, information obtained from standard blood glucose monitoring devices, and is not recommended for people who are unwilling or unable to perform a minimum of two meter blood glucose tests per day, or for people who are unable or unwilling to maintain contact with their healthcare professional. The system requires a functioning mobile electronic device with correct settings. If the mobile device is not set up or used correctly, you may not receive sensor glucose information or alerts. For complete details of the system and its components, including warnings, contraindications, and precautions, please consult the user guide and important safety information.
Important Safety Information: CareLink™ Software
The CareLink™ software is intended for use as a tool to help manage diabetes. The purpose of the software is to take information transmitted from insulin pumps, glucose meters and continuous glucose monitoring systems, and turn it into CareLink™ reports. The reports provide information that can be used to identify trends and track daily activities—such as carbohydrates consumed, meal times, insulin delivery, and glucose readings. NOTE: CareLink™ report data is intended for use as an adjunct in the management of diabetes only and NOT intended to be relied upon by itself. Patients should consult their healthcare providers familiar with the management of diabetes prior to making changes in treatment. For more details, please consult important safety information. and the appropriate CareLink™ User Guide.